A total of 710 pigs (Line 400 × 200, DNA, Columbus, net energy (NE)) were used in two experiments (Exp. 1: initially, 6.3 ± 0.05 kg; Exp. 2: initially, 6.8 ± 0.05 kg) to evaluate the effects of two medium-chain fatty acid (MCFA) based products on nursery pig growth performance. Following their arrival at the nursery facility, pigs were randomized to pens (five pigs per pen) and allowed a 4-d acclimation period. Thereafter, pens of pigs were blocked by initial weight and randomized to dietary treatment. In Exp. 1, the dietary treatments were a dose titration of: 0%, 0.5%, 1.0%, or 2.0% MCFA-based additive, as well as a diet including 1.0% MCFA from a 1:1:1 blend of C6:0, C8:0, and C10:0. In Exp.2, dietary treatments consisted of a basal diet containing no MCFA (control), the control diet with a 1.0% inclusion of four different blends of MCFA, lactic acid, and monolaurin or a diet with 1.0% added MCFA (a 1:1:1 blend of C6:0, C8:0, and C10:0). The four blends consisted of 50% C6:0, 20% lactic acid, and increasing levels of monolaurin (0%, 10%, 20%, and 30%) at the expense of C12:0 (30%, 20%, 10%, and 0%). Treatment diets were formulated and manufactured in two dietary phases. Data were analyzed as a randomized complete block design with pen as the experimental unit. In Exp. 1, overall (days 0–34), increasing CaptiSURE increased (linear, P ≤ 0.014) average daily gain (ADG) and average daily feed intake (ADFI). Feed efficiency improved (quadratic, P = 0.002) with increasing CaptiSURE up to 1.0% of the diet with no benefit thereafter. There was no evidence for differences between pigs fed 1.0% CaptiSURE and pigs fed the 1.0% MCFA blend of C6:0, C8:0, and C10:0. In Exp. 2, overall (days 0–35), pigs fed the 1.0% 1:1:1 MCFA blend had increased (P < 0.034) ADFI and ADG resulting in 0.9 kg greater final weight (P = 0.014) compared with the control group. There was no evidence that the mean performance of pigs fed the four blends of MCFA, lactic acid, and monolaurin were different from the pigs fed the control diet. In summary, the addition of a 1.0% 1:1:1 blend of C6:0, C8:0, and C10:0 in nursery pig diets improved ADG, ADFI, and gain to feed ratio (G:F) compared with pigs fed the control diet. In addition, providing nursery pigs with the MCFA product CaptiSURE, up to 2% of the diet, resulted in linear improvements in ADG and ADFI. Altering the C12:0 to monolaurin ratio and adding lactic acid did not improve growth performance compared with pigs fed the control diet.
Previous studies have shown that the inclusion of medium chain fatty acids (MCFA) results in an improvement in nursery pig performance. Therefore, the objective of this study was to evaluate a proprietary C8:C10 MCFA blend (CaptiSURE, Kemin Industries, Inc., Des Moines, IA) on nursery pig performance. A total of 360 weaned piglets (initial BW = 6.1 kg) were randomly assigned to a control (no MCFA blend) or 10 kg/t MCFA blend (10 pigs/pen, 18 replicate pens/treatment), in which MCFA blend was substituted at the expense of tallow at a 1:1 rate. Diets were manufactured in 3 dietary phases (d 0–7, 7–21, and 21–42) in pelleted form. Due to an unintended bacterial challenge at the sow farm, pigs were treated with amoxicillin using a pulse protocol (48 hrs on / 48 hrs off) from placement to d 21. Data were analyzed using the students T-test procedure, and pen served as the experimental unit. Within dietary phase 2 (d 7–21), the inclusion of MCFA blend improved ADG (264g vs 326g, P = 0.017) and G:F (0.79 vs 0.89, P = 0.005), while exhibiting a trend to improve ADFI (330g vs 364g, P = 0.080). Within dietary phase 3 (d 21–42), the inclusion of MCFA blend improved ADG (518g vs 581g, P = 0.024) and ADFI (719g vs 799g, P = 0.006). Overall (d 0–42), the inclusion of MCFA blend improved ADG (379g vs 438g, P = 0.007), ADFI (503g vs 0.562g, P = 0.009), and G:F (0.75 vs 0.78, P = 0.042), resulting in a 2 kg heavier pig (P = 0.043). In summary, the inclusion of a proprietary C8:C10 MCFA blend at 1.0% in nursery pig diets improved growth performance.
A total of 350 pigs (DNA 400 × 200, initial BW = 13.8 lb) were used in a 34-d growth trial to evaluate the effects of increasing a medium chain fatty acid (MCFA)-based feed additive in nursery pig diets. Following arrival to the nursery research facility, pigs were randomized to pens (5 pigs per pen) and allowed a 4-d acclimation period. Thereafter, pens of pigs were blocked by body weight (BW) and randomized to 1 of 5 dietary treatments (14 pens per treatment). Treatments were constructed such that a dose response was created including 0, 0.5, 1.0, and 2.0% MCFA-based additive (CaptiSURE, Kemin Industries, Inc., Des Moines, IA) as well as a treatment including a 1.0% MCFA blend of C6, C8, and C10 (1:1:1 ratio; Sigma Aldrich, St. Louis, MO). Treatment diets were formulated and manufactured in two dietary phases (d 0 to 13 and 13 to 34). Overall (d 0 to 34), increasing CaptiSURE increased (linear, P ≤ 0.014) average daily gain (ADG) and average daily feed intake (ADFI). Feed efficiency improved (quadratic, P = 0.002) with increasing CaptiSURE up to 1% of the diet with no benefit thereafter. As a result of these linear improvements in ADG, pigs fed 2.0% CaptiSURE were 4 lb heavier (P = 0.05) than pigs consuming diets without MCFA at d 34. There was no evidence for differences between the pigs fed 1.0% CaptiSURE and the 1.0% MCFA blend of C6, C8, and C10 in phase 1, phase 2, or in overall performance. In summary, the addition of this MCFA-based additive in nursery pig diets resulted in a linear improvement in ADG and ADFI. Based on these results, this MCFA feed additive appears to result in a similar improvement in growth performance as the C6, C8, and C10 MCFA blend when both are added at 1% of the diet. Additional research is warranted under commercial conditions to determine if similar advantages in growth performance are observed and if they provide an economic return.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.